Protease inhibitor-based therapy is associated with decreased HIV- related health care costs in men treated at a veterans administration hospital

Medicine & Life Sciences

• Veterans Hospitals 100%
• United States Department of Veterans Affairs 90%
• Protease Inhibitors 76%
• Health Care Costs 66%
• HIV 51%
• Costs and Cost Analysis 46%
• Ambulatory Care 39%
• Outpatients 21%
• Inpatients 18%
• Nucleosides 18%
• Therapeutics 12%
• Linear Models 8%
• Hospitalization 8%
• HIV Protease Inhibitors 8%
• Statistical Models 6%
• Opportunistic Infections 6%
• Veterans 5%
• Ambulatory Care Facilities 5%
• HIV Infections 5%
• Communicable Diseases 4%
• Hospital Emergency Service 4%
• Analysis of Variance 4%
• Emergencies 4%